A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT ID: NCT00240318
Last Updated: 2010-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
450 participants
INTERVENTIONAL
2002-11-30
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rosuvastatin calcium
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Clinically significant heart disease which, in the opinion of the Principal Investigator (or designee), is likely to require coronary bypass surgery, cardiac transplantation, surgical repair and/or replacement during the course of the study.
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca Crestor Medical Sciences Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Birmingham, Alabama, United States
Research Site
Los Angeles, California, United States
Research Site
San Francisco, California, United States
Research Site
Santa Rosa, California, United States
Research Site
Stockton, California, United States
Research Site
Denver, Colorado, United States
Research Site
Hartford, Connecticut, United States
Research Site
Atlantis, Florida, United States
Research Site
Chicago, Illinois, United States
Research Site
Maywood, Illinois, United States
Research Site
Auburn, Maine, United States
Research Site
Baltimore, Maryland, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Petoskey, Michigan, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Saint Paul, Minnesota, United States
Research Site
Buffalo, New York, United States
Research Site
Valhalla, New York, United States
Research Site
Williamsville, New York, United States
Research Site
Chapel Hill, North Carolina, United States
Research Site
Toledo, Ohio, United States
Research Site
Danville, Pennsylvania, United States
Research Site
Houston, Texas, United States
Research Site
Milwaukee, Wisconsin, United States
Research Site
Auchenflower, , Australia
Research Site
Clayton, , Australia
Research Site
Heidelberg, , Australia
Research Site
New Lambton, , Australia
Research Site
Aalst, , Belgium
Research Site
Brussels, , Belgium
Research Site
Edegem, , Belgium
Research Site
Liège, , Belgium
Research Site
Halifax, Nova Scotia, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Ste-Foy, Quebec, Canada
Research Site
Créteil, , France
Research Site
Limoges, , France
Research Site
Lyon, , France
Research Site
Massy, , France
Research Site
Melun, , France
Research Site
Paris, , France
Research Site
Pessac, , France
Research Site
Toulouse, , France
Research Site
Rozzano, Milan, Italy
Research Site
Mirano, Venezia, Italy
Research Site
Genova, , Italy
Research Site
Milan, , Italy
Research Site
Pavia, , Italy
Research Site
Pisa, , Italy
Research Site
Rome, , Italy
Research Site
Siena, , Italy
Research Site
Udine, , Italy
Research Site
Amsterdam, , Netherlands
Research Site
Maastricht, , Netherlands
Research Site
Nieuwegein, , Netherlands
Research Site
Zwolle, , Netherlands
Research Site
Barcelona, , Spain
Research Site
Madrid, , Spain
Research Site
Málaga, , Spain
Research Site
Murias, , Spain
Research Site
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006 Apr 5;295(13):1556-65. doi: 10.1001/jama.295.13.jpc60002. Epub 2006 Mar 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D3562C00076
Identifier Type: -
Identifier Source: org_study_id